Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2005
08/18/2005US20050181359 Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
08/18/2005US20050181357 Nucleotide sequences comprisied of spike and nucleocapsid coding sequence for use as amplification tool in detection of coronaviral infection
08/18/2005US20050181356 Hepatitis c virus assay systems
08/18/2005US20050181355 Compositions and methods for the modulation of viral maturation
08/18/2005US20050181064 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith
08/18/2005US20050180996 Vaccine composition specific to glyceroaldehyde-3-phosphate dehydrogenase for use as tool in prevention and treatment of coccidiosis; veterinary medicine
08/18/2005US20050180982 Assessing metastatic potential of carcinoma cells by contacting cells in tissue sample suspected of containing carcinoma with detectable indicator capable of binding to cad-11 or cad-11 mRNA and determining presence or absence of cad-11 expression in tissue; method of preventing or terminating pregnancy
08/18/2005US20050180981 Human checkpoint kinase, hCDS1, compositions and methods
08/18/2005US20050180980 Novel antibody recognizing a small subset of human hematopoietic cells
08/18/2005US20050180976 Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases
08/18/2005US20050180973 TREM-1 splice variant for use in modifying immune responses
08/18/2005US20050180959 Kinases involved in the regulation of energy homeostasis
08/18/2005US20050180955 gene therapy; delivering recombinant adeno-associated virus virions to the brain; pumping; transgene encodes an aromatic amino acid decarboxylase
08/18/2005US20050180951 Fusion of autologous dendrtic cells with cancer cells that have the same class I MHC haplotype as said patient; and interleukin-12
08/18/2005US20050180890 Base plate comprising a thermal structure; releasably attached to the drive system for rotation; can be adapted to use with different test protocols
08/18/2005US20050180880 Biochemical reaction cartridge
08/18/2005US20050178726 mechanically disrupted, preferably in 45 seconds or less; nucleic acid extraction from lymph node samples; disruption element having an outer dimension that is slightly smaller than the inside dimension of container
08/18/2005DE102004032460B3 In vitro synthesis of expression products, particularly proteins, in a cell-free system, comprises using a repetitive batch method, with periodic removal of metabolites and supplementation
08/18/2005CA2585231A1 Self-assembling split-fluorescent protein systems
08/18/2005CA2556259A1 Therapeutic molecules and methods for generating and/or selecting same
08/18/2005CA2555469A1 Use of relaxin-3 for promoting food intake, increasing body weight gain, increasing fat weight and for others
08/18/2005CA2555463A1 Inhibitors of tgf-r signaling for treatment of cns disorders
08/18/2005CA2555346A1 Method of detecting nucleic acid and utilization thereof
08/18/2005CA2555332A1 Regulation of gene expression in plant cells
08/18/2005CA2555317A1 Process for producing optically active alcohol and carboxylic acid
08/18/2005CA2555306A1 Humanized antibody
08/18/2005CA2555224A1 Watermelon varieties having altered sugar ratios
08/18/2005CA2555083A1 Genes associated with canine osteoarthritis and related methods and compositions
08/18/2005CA2554885A1 Generation of recombinant genes in saccharomyces cerevisiae
08/18/2005CA2554822A1 Angiogenesis inhibitors, compositions containing same and use thereof for treating diseases related to angiogenetic deregulation
08/18/2005CA2554784A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
08/18/2005CA2554780A1 Method of producing recombinant sucrose synthase, use thereof in the production of sucrose-determination kits, method of producing adpglucose and method of obtaining transgenic plants having leaves and reserve organs which accumulate a high concentration of adpglucose and starch
08/18/2005CA2554644A1 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use
08/18/2005CA2554634A1 Compositions, methods and uses for a novel family of peptides
08/18/2005CA2554628A1 Methods of modulating cd200 and cd200r
08/18/2005CA2554526A1 Variants of the extracellular domain of bcma and uses thereof
08/18/2005CA2554431A1 Genetic markers for skatole metabolism
08/18/2005CA2554362A1 Treatment of neurodegenerative diseases by the use of atp7a inhibitors
08/18/2005CA2554218A1 Screening assays
08/18/2005CA2554027A1 Biochip electroporator and its use in multi-site, single-cell electroporation
08/18/2005CA2553886A1 Combined use of prame inhibitors and hdac inhibitors
08/18/2005CA2553683A1 Detection of ruminant dna via pcr
08/18/2005CA2553040A1 Modified human four helical bundle polypeptides and their uses
08/18/2005CA2553035A1 Modified human growth hormone polypeptides and their uses
08/18/2005CA2553034A1 Modified human interferon polypeptides and their uses
08/18/2005CA2497600A1 Disruption of cells and tissues
08/17/2005EP1564304A1 Method of DNA array construction, gene expression analysis, and discovery of useful genes
08/17/2005EP1564303A2 Strand displacement amplification of RNA targets
08/17/2005EP1564301A1 Method of amplifying nucleic acid
08/17/2005EP1564300A1 Hethod of amplifying nucleic acid and apparatus therefor
08/17/2005EP1564299A1 Method of screening for compounds that inhibit the enzymatic activity of gwt1 gene product
08/17/2005EP1564298A1 Enzymatic asymmetric decarboxylation of disubstituted malonic acids
08/17/2005EP1564297A1 Control of programmed cell death (PCD) in plants
08/17/2005EP1564296A1 Stress tolerance and delayed senescence in plants
08/17/2005EP1564295A1 RNA virus-derived plant expression system
08/17/2005EP1564294A1 Improved cloning vector containing marker inactivation system
08/17/2005EP1564293A1 Neural thread protein gene expression and detection of Alzheimer's disease
08/17/2005EP1564292A1 Pharmaceutical compositions and methods of treatment based on VEGF antisense oligonucleotides
08/17/2005EP1564291A2 Oligonucleotides, agents containing them and their use
08/17/2005EP1564290A2 Nucleic acid ligands of tissue targets
08/17/2005EP1564289A1 Stabilization of linear double-stranded DNA in the presence of exonucleases
08/17/2005EP1564288A1 Function-modified thermophilic DNA polymerase
08/17/2005EP1564287A1 Method of predicting genetic risk for hypertension
08/17/2005EP1564286A1 Hybrid proteins of beta-lactamase class A
08/17/2005EP1563907A2 Biochemical reaction cartridge
08/17/2005EP1563886A1 Extraction system
08/17/2005EP1563836A1 Drug for inhibiting production of matrix metalloprotease-9
08/17/2005EP1563834A1 Hollow nanoparticles of protein and drug using the same
08/17/2005EP1563729A1 Nonhuman model animal suffering from guillain-barre syndrome and/or fisher syndrome
08/17/2005EP1563727A1 Methods for coupling resistance alleles in tomato
08/17/2005EP1563444A2 Method for producing virtual chromosomes
08/17/2005EP1563092A2 Assays and methods based on microcompetition with a foreign polynucleotide
08/17/2005EP1563091A2 Methods and materials for using chemical compounds as a tool for nucleic acid storage on media of nucleic acid purification systems
08/17/2005EP1563089A2 Solid phase based nucleic acid assays combining high affinity and high specificity
08/17/2005EP1563084A2 Transgenic ungulates having reduced prion protein activity and uses thereof
08/17/2005EP1563080A1 Method for expressing inducible rnai in cells, nucleic acid molecules therefor and cells transformed by said molecules
08/17/2005EP1563079A2 Method of controlling cellular processes in plants
08/17/2005EP1563078A1 Method of controlling a cellular process in a multi-cellular organism
08/17/2005EP1563077A2 Method of controlling gene expression in plants or plant cells
08/17/2005EP1563076A2 Selective expression in filamentous fungi
08/17/2005EP1563075A1 Plasmids expressing human insulin and the preparation method for human insuling thereby
08/17/2005EP1563072A2 Dna sequences from tcd genomic region of photorhabdus luminescens
08/17/2005EP1563071A2 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof
08/17/2005EP1563070A2 2'-substituted oligomeric compounds and compositions for use in gene modulations
08/17/2005EP1563069A2 Compositions and systems for the regulation of genes
08/17/2005EP1563067A2 Methods for the identification of agents that modulate the structure and processing of a membrane bound precursor protein
08/17/2005EP1563066A2 Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein
08/17/2005EP1563060A2 Tps plant gene constructs and transformants
08/17/2005EP1563059A1 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders
08/17/2005EP1563057A1 Method for producing riboflavin
08/17/2005EP1563056A2 Composition and method for treating lupus nephritis
08/17/2005EP1562987A2 Use of edg2 receptor in an animal model of heart failure
08/17/2005EP1562981A2 Ligands
08/17/2005EP1562971A2 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
08/17/2005EP1562970A2 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF HIF-1 ALPHA
08/17/2005EP1562969A2 Novel human cell surface protein with immunoglobulin folds, bgs-19
08/17/2005EP1562968A1 Anti-il-6 antibodies, compositions, methods and uses
08/17/2005EP1562967A2 Adipocyte complement related protein zacrp14
08/17/2005EP1562963A1 Novel lipophilic compounds and uses thereof
08/17/2005EP1562635A2 Modified dendritic cells
1 ... 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 ... 4023